Invention Grant
- Patent Title: Method and device for lymphedema treatment
-
Application No.: US15028391Application Date: 2014-10-10
-
Publication No.: US11273235B2Publication Date: 2022-03-15
- Inventor: Catarina Hadamitzky , Tatiana Zaitseva , Michael V. Paukshto
- Applicant: Fibralign Corporation
- Applicant Address: US CA Union City
- Assignee: Fibralign Corporation
- Current Assignee: Fibralign Corporation
- Current Assignee Address: US CA Union City
- Agency: DLA Piper LLP (US)
- International Application: PCT/US2014/060164 WO 20141010
- International Announcement: WO2015/054654 WO 20150416
- Main IPC: A61L27/24
- IPC: A61L27/24 ; A61L27/54 ; A61L27/58 ; A61L27/60 ; A61K38/18 ; A61K35/26 ; A61K35/16 ; A61B18/20 ; A61F2/10 ; A61L27/36 ; A61L27/50 ; A61M5/142 ; A61M25/01 ; A61M27/00

Abstract:
Materials and methods are provided to direct the formation of new lymphatics and to reconnect the disrupted lymphatic network. These materials and methods enable to improve survival of lymph nodes and lymph node fragments and their integration into a lymphatic network, following lymph node and lymph node fragments transplantation. The treatment or prevention of lymphedema is also addressed. In certain embodiments, a bundle of fibers or fibrils presented in the composition is effective to stimulate and direct the formation of new lymphatic and blood vessels. The bundle of fibers or fibrils presented in the composition is effective to promote survival of the lymph node or lymph node fragments and integration of the lymph node or lymph node fragments into a lymphatic network in the mammalian subject, at the site of transfer or transplantation.
Public/Granted literature
- US20160256605A1 Method And Device For Lymphedema Treatment Public/Granted day:2016-09-08
Information query